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The unfolded protein response (UPR) is linked to
metabolic dysfunction, yet it is not known how endo-
plasmic reticulum (ER) disruption might influence
metabolic pathways. Using a multilayered genetic
approach, we find that mice with genetic ablations
of either ER stress-sensing pathways (ATF6a,
eIF2a, IRE1a) or of ER quality control (p58IPK) share
a common dysregulated response to ER stress that
includes the development of hepatic microvesicular
steatosis. Rescue of ER protein processing capacity
by the combined action of UPR pathways during
stress prevents the suppression of a subset of meta-
bolic transcription factors that regulate lipid homeo-
stasis. This suppression occurs in part by unresolved
ER stress perpetuating expression of the transcrip-
tional repressor CHOP. As a consequence,metabolic
gene expression networks are directly responsive to
ER homeostasis. These results reveal an unantici-
pated direct link between ER homeostasis and the
transcriptional regulation of metabolism, and sug-
gest mechanisms by which ER stress might underlie
fatty liver disease.
INTRODUCTION
Cellular protein folding homeostasis is protected when the deple-
tion of chaperone reserve leads to the activation of proximal
signaling molecules, which ultimately results in alterations in
gene expression to alleviate stress. In the endoplasmic reticulum
(ER), three principal pathways are activated in response to ER
stress and comprise the unfolded protein response (UPR): pan-
creatic ER eukaryotic translation initiation factor (eIF)-2a kinaseDevelop(PERK), inositol-requiring enzyme (IRE)-1, and activating tran-
scription factor (ATF)-6. PERK and IRE1 are ER-resident trans-
membrane kinases that lead to translational inhibition through
eIF2a phosphorylation, and production of X-box binding protein
(XBP)-1 transcription factor by an unconventional splicing mech-
anism, respectively. ATF6 is a transmembrane transcription
factor liberated by stress-regulated intramembrane proteolysis.
Each pathway culminates in transcriptional regulation of gene
expression and contributes to the overall maintenance of homeo-
stasis in the ER during stress (Ron and Walter, 2007; Schro¨der,
2008; Wek and Cavener, 2007; Wu and Kaufman, 2006). Gene
expression profiling has demonstrated that numerous cellular
processes beyond protein folding in the ER are regulated by
UPR activation (Harding et al., 2003; Shen et al., 2005; Travers
et al., 2000). However, how these processes are activated and
temporally regulated by ongoing stress, and how such regulation
alters cellular functions only tangentially related to secretory
pathway function to improve the chances for adaptation, is not
understood.
ER stress has been associated with metabolic dysfunction
caused by dietary demand (Lee et al., 2008; Oyadomari et al.,
2008; O¨zcan et al., 2004, 2006). How the various pathways of
the UPR protect cells from stress in vivo, and how these path-
ways intersect with other cellular functions, such as metabolism,
in different circumstances is not clear. Thus there is a need to
examine the functions of the individual UPR signaling pathways
in parallel and in vivo. The liver presents an ideal model system
for studying these connections, because it is a key organ for
both protein secretion (principally in the form of lipoproteins
and other serum factors) and metabolism (Postic et al., 2004).
The coupling of these processes involves families of transcrip-
tional activators and coregulators. Among these are members
of the CCAAT/enhancer binding protein (C/EBP), peroxisome
proliferator-activated receptor (PPAR), PPAR-g coactivator
(PGC)-1, and sterol response element binding protein (SREBP)
families, which reprogram liver metabolic mRNA expression asmental Cell 15, 829–840, December 9, 2008 ª2008 Elsevier Inc. 829
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2003; Lekstrom-Himes and Xanthopoulos, 1998; Lin et al.,
2005). Liver function is also sensitive to environmental or genetic
perturbation, and a number of these perturbations, including both
alcoholic and nonalcoholic steatohepatitis, viral hepatitis, hyper-
homocysteinemia, acute exposure to hepatotoxins, and high
carbohydrate or high fat diets, have been suggested to lead to
hepatic ER stress (Jaeschke et al., 2002; Lee et al., 2008; Nguyen
et al., 2008; Oyadomari et al., 2008). A common thread among
these insults is disruption of lipid homeostasis (i.e., fatty acid
metabolism) in the liver. Elements of the UPR, including the tran-
scription factor XBP1 and the translational regulator eIF2a, have
been proposed to directly regulate lipid metabolic pathways (Lee
et al., 2008; Oyadomari et al., 2008). However, it is not clear
whether these interactions are influenced by ER stress, whether
they are pathway specific, or whether they apply equally to the
many diverse causes of hepatic dyslipidemia.
ATF6a protects ER function by augmenting the upregulation of
ER protein processing factors, such as chaperones and ER-
associated protein degradation (ERAD) machinery during stress
(Adachi et al., 2008; Wu et al., 2007; Yamamoto et al., 2007).
ATF6a deletion sensitizes cells and animals to persistent ER
stress. In vivo, this failure to recover from ER stress results in
fatty liver, uncovering a potential connection between ER stress
and lipid metabolism (Wu et al., 2007). In this study, we have
used a genetic approach to identify the proximal mechanistic
connections between activation of the UPR by ER stress and
metabolic control. This approach has revealed that the three
arms of the UPR cooperate to maintain ER function, and that
failure to do so leads to unresolved ER stress and suppression
of several key regulators of metabolic gene expression indepen-
dent of any specific UPR pathway. These results suggest that
an intact UPR guards liver function by improving ER protein
processing to maintain lipid homeostasis.
RESULTS AND DISCUSSION
Unresolved ER Stress Perturbs Hepatic
Lipid Homeostasis
Animals nullizygous for the Atf6a gene display no overt pheno-
type under unchallenged conditions, being viable, fertile, and
grossly normal. However, when injected intraperitoneally with
an ordinarily sublethal dose of the ER stress-inducing agent tuni-
camycin (TM),Atf6a-null animals succumb and show evidence of
persistent ER stress in the liver and kidneys (Wu et al., 2007). Con-
sistent with our previous findings, TM-challenged Atf6a-null ani-
mals displayed prolonged upregulation of the apoptotic protein,
C/EBP-homologous protein (CHOP), and its target GADD34 at
a time when the expression of these genes is attenuated in
wild-type animals (Figure 1A). While adaptation to or recovery
from ER stress is accompanied by rapid degradation of Chop
mRNA and protein (Rutkowski et al., 2006), persistent CHOP
Figure 1. ATF6a Deletion Reveals an Inter-
section between ER Stress and Metabolic
Homeostasis
(A) Livers from wild-type, heterozygous, or
Atf6a-null mice injected with vehicle or 1 mg/kg
body weight TM were probed by immunoblot for
expression of tubulin (loading control) BiP,
CHOP, GADD34, and the phosphorylated form of
eIF2a. Efficacy of the TM was reflected in inhibition
of TRAPa glycosylation, for which the glycosylated
(closed arrow) and unglycosylated (open arrow)
species are indicated.
(B) Wild-type and Atf6a/mice were injected with
1 mg/kg TM and livers were visualized in situ at the
indicated times postinjection.
(C) Wild-type andAtf6a/mice were injected with
TM. Cryosections (6 mm) of liver isolated 48 hr
postinjection were stained with H&E and visual-
ized at 4003 magnification.
(D) Wild-type andAtf6a/mice were injected with
vehicle (NT, not treated) or TM (1 mg/kg). Livers
were surgically removed 48 hr postinjection, fixed
in 2.5% glutaraldehyde, then prepared for trans-
mission electron microscopic analysis. ER, endo-
plasmic reticulum; LD, lipid droplets; N, nuclei;
M, mitochondria. Scale bar, 500 nm.
(E) Protein lysates from liver, isolated 8 or 48 hr
postinjection, were probed by immunoblot as
labeled. RNA was prepared from the same liver
tissue samples and assayed by RT-PCR that
simultaneously detects both spliced (sp) and
unspliced (us) Xbp1 mRNA.
(F) Mice were injected with 1 mg/kg TM for 48 hr.
Mice were fasted for 6 hr and then injected with in-
sulin (2 U/kg) 20 min prior to being sacrificed. Im-
munoblotting detected phosphorylated or total
AKT.
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Unresolved ER Stress Causes Steatosisexpression correlates with unresolved stress. The most likely
cause of this persistent stress is a failure of Atf6a-null animals
to fully upregulate ER protein folding and processing machinery
(Wu et al., 2007; Yamamoto et al., 2007), which renders them
less able to recover from acute challenge.
Also consistent with our previous results (Wu et al., 2007), wild-
type or heterozygous animals challenged with TM showed initial
liver perturbation at the molecular and morphological levels, but
recovered thereafter, while Atf6a/ animals failed to recover.
By 48 hr after injection, livers ofAtf6a/ animals were much ligh-
ter in color than wild-type counterparts, and produced a distinct
fat cap upon homogenization and sedimentation (Figure 1B and
data not shown). Hematoxylin and eosin (H&E) failed to stain large
swaths of Atf6a/ liver tissue after TM injection, Oil Red O stain-
ing confirmed the presence of fat deposits, and substantially
more intracellular triglyceride was found in Atf6a-null animals
than in the wild-type (Figure 1C, and data not shown; see
Figure S1 available online). Ultrastructural analysis revealed a
uniform accumulation of cytosolic lipid droplets in knockout
livers, indicative of microvesicular steatosis (Figure 1D). In addi-
tion, while TM induced breakdown of the lamellar structure of
the ER into smaller vesicles in wild-type animals, Atf6a-null ani-
mals appeared to show an even greater loss of structural integrity
of the ER (Figure 1D). Confirming the accumulation of lipid, the cy-
tosolic lipid droplet protein marker adipose differentiation-related
protein (ADRP) (Martin and Parton, 2006) was upregulated by ER
stress in all genotypes, but more so in Atf6a-null animals (Fig-
ure 1E). This accumulation of lipid occurred concomitant with
the persistent presence of XBP1 protein derived from spliced
mRNA, which reflects ongoing stress (Figure 1E and Figure S2).
Thus, lipid accumulation in the livers of Atf6a-null animals is an
active process that accompanies persistent UPR signaling.
Similar fat accumulation and ADRP upregulation were seen in
the kidneys of TM-challenged Atf6a-null animals (Figure S3).
ER stress and fat deposition were not observed in other tissues,
consistent with liver and kidneys being the primary target organs
of TM (Hetz et al., 2006; Marciniak et al., 2004; Zinszner et al.,
1998). BecauseAtf6a deletion produced such a dramatic pheno-
type upon challenge, but did not otherwise result in lethality (in
contrast to constitutive ablation of IRE1a or eIF2a signaling
[Harding et al., 2001; Reimold et al., 2000; Scheuner et al.,
2001; Zhang et al., 2005]), we used this genetic model to further
explore how ER stress influences lipid metabolism.
Injection of wild-type animals with a higher dose of TM (2 mg/kg
body weight rather than 1 mg/kg) led to animal mortality along
a similar time frame as the lower dose in Atf6a-null animals
(3 days after injection, data not shown). However, this higher
dose only modestly increased lipid deposition in wild-type ani-
mals (Figures 1C and 1E). This result suggests that the divergent
phenotype of Atf6a-null animals is not simply a consequence of
increased toxicity of TM in these animals. Several additional lines
of evidence support this hypothesis. First,Atf6a/ animals were
capable of upregulating cytochrome P450 isoforms, which de-
toxify compounds in the liver, in response to TM or other chal-
lenge (Figure S4 and data not shown). Second, TM injection led
to only very modest increases in plasma alanine transaminase
levels in Atf6a-null animals compared to wild-type animals, and
only at very late time points after injection, arguing against gross
hepatic necrosis or apoptosis (Figure S5). Third, hepatocellularDevelopapoptosis, judged by cleavage of the nuclear PARP protein,
was not significantly increased in Atf6a-null animals compared
with the wild-type (Figure S5).
While steatosis is the most obvious consequence of TM injec-
tion in Atf6a-null mice, other metabolic pathways are progres-
sively perturbed as well. One consequence of fat accumulation
in the liver is the development of insulin resistance (Postic and
Girard, 2008). Challenge of wild-type animals with TM rendered
them resistant to signaling by endogenous insulin produced by
refeeding after fasting, as assessed by phosphorylation of murine
thymoma viral (v-akt) oncogene homolog-1 (AKT) at Ser473, con-
sistent with the idea that ER stress produces insulin resistance
(O¨zcan et al., 2004) (Figure S6). However, on top of this stress-
dependent resistance to endogenous insulin, we observed resis-
tance toexogenous insulin inAtf6a-null animals, but not wild-type
animals, by 48 hr after TM injection (Figure 1F). Thus, while both
wild-type and Atf6a-null animals became resistant to endoge-
nous insulin during ER stress, Atf6a-null animals eventually be-
came profoundly resistant to even exogenous insulin, concomi-
tant with lipid dysregulation. Atf6a-null animals also displayed
hypoglycemia and reduced glycogen storage (data not shown)
consistent with gross metabolic disruption in the liver. Combined
with the lipid deposition phenotype, these results suggest that
TM treatment perturbs metabolic homeostasis and that this
phenotype becomes progressively more severe, selectively in
Atf6a-null animals.
ER Stress Suppresses Expression of Genes Involved
in Maintaining Energy and Lipid Homeostasis
Because ATF6a is a transcription factor, we reasoned that the
connection between Atf6a deletion and disruption of lipid ho-
meostasis might be most readily identified by global transcrip-
tional analysis. Microarray profiling 8 hr after TM challenge
revealed that, as in mouse embryonic fibroblasts (MEFs) (Adachi
et al., 2008; Wu et al., 2007), Atf6a deletion had little effect on
basal gene expression (Figure 2A and Supplemental Data). How-
ever, when animals were challenged with TM for 8 hr, a subset of
ER stress-regulated genes was altered in their expression by
Atf6a deletion (Figure 2A). The majority of these were genes
that were upregulated by stress in wild-type liver, and either to
a lesser or greater extent in Atf6a-null animals. As in MEFs, the
expression of ER chaperones and cochaperones (Erp72,
Erp57, p58IPK, Grp94), as well as genes involved in ERAD
(Derl3, Edem1), was attenuated in Atf6a-null livers (Figure 2B).
In addition, early upregulation of the gene encoding the proapop-
totic transcription factor CHOP depended partially upon ATF6a.
Notably, there was no obvious connection between Atf6a
deletion and expression of genes involved in hepatic lipid metab-
olism, consistent with the phenotypic separation between
genotypes developing progressively and manifesting more so
at later time points rather than only 8 hr after challenge. However,
we observed that a number of key mediators of lipid homeostasis
were significantly downregulated by TM independent of geno-
type (Figure 2C and Table S1). These included genes encoding
the transcription factors and cofactors, SREBP1, C/EBPa,
PPARa, FOXO1, and PGC1a, and components of lipid metabo-
lism, including microsomal triglyceride transfer protein (MTTP),
fatty acid desaturases and synthetases (FADS-1 and -2, and
fatty acid synthase [FASN]), and 3-hydroxy-3-methylglutarylmental Cell 15, 829–840, December 9, 2008 ª2008 Elsevier Inc. 831
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Unresolved ER Stress Causes SteatosisFigure 2. Persistent ER Stress In Vivo Suppresses Expression of a Subset of Metabolic Genes
(A) Cluster analysis of gene expression and transcriptional profiling analysis of liver RNAs were performed as described in the Experimental Procedures. Graphic
representation of the average expression levels of 4262 differentially expressed genes is shown. Each vertical bar represents a single gene. Green coloration
indicates lower expression, and red indicates higher expression.
(B and C) The expression levels of two subsets of mRNAs from microarray analysis are shown, normalized against vehicle-injected wild-type samples. Note that
the differences in expression levels of these genes in the absence of ER stress were generally not significant. Data represent means ± SD from three animals in
each group. For (B), all genes shown were significantly (p < 0.05) less induced by TM in Atf6a-null animals than wild-type animals. For (C), all genes shown were
significantly (p < 0.05) downregulated by stress in both genotypes. The ATF4-dependent tryptophanyl tRNA synthetase (Wars) is here Atf6a dependent, likely
because of the failure of Atf6a-null mice to stimulate eIF2a phosphorylation in response to TM challenge.
(D) Real-time RT-PCR analysis was used to assess the expression of selected mRNAs in wild-type or Atf6a-null livers 8 or 48 hr after TM injection. Data represent
means ± SD from two (vehicle) or three (TM) animals. Expression values were normalized against b-actin levels and are shown relative to the expression level in
wild-type unchallenged animals. Red lettering indicates genes significantly (p < 0.05) different in expression comparing TM-challenged Atf6a-null animals to
unchallenged animals.
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Unresolved ER Stress Causes Steatosiscoenzyme A (CoA) reductase. This regulation was selective only
for a subset of metabolic genes in that the expression of many
others was unaltered after 8 hr of ER stress (Table S1).
Deletion ofAtf6adoes not immediately sensitize cells to stress,
but instead renders them less able to recover from and adapt to
ongoing stress (Wu et al., 2007). Indeed, the initial response of the
liver to TM injection in Atf6a-null mice was very similar to that of
wild-type mice in terms of activation of ER stress pathways,
and it was only at later time points that knockout animals showed
persistent ER stress when wild-type animals had recovered
(Figure 1A). Thus, we speculated that Atf6a deletion might sensi-
tize animals to ER stress, not by loss of direct regulation of
metabolic gene expression by ATF6a, but instead by indirectly
leading to ongoing stress in the liver because of failure to properly
improve the protein folding environment in the ER. In support
of this hypothesis, quantitative RT-PCR demonstrated that
expression of the genes Mttp, Srebp1, Pgc1a, and Ppara was
suppressed by ER stress in both wild-type andAtf6a-null animals
8 hr after TM injection, but to a much greater extent in Atf6a-null
animals 48 hr after injection (Figure 2D). Expression of C/ebpa
mRNA and protein followed a similar trend, being rapidly sup-
pressed by TM in both genotypes, but remaining suppressed in
Atf6a-null animals over the course of the experiment (Figure 2E
and data not shown). C/EBPa protein is synthesized in both
long (p42) and short (p30) forms by virtue of translational regula-
tion (Calkhoven et al., 2000) and, consistent with the decrease
in C/ebpa mRNA, both forms were suppressed in Atf6a-null ani-
mals. We also observed upregulation of c-jun at both the mRNA
and protein levels (Figure 2E and data not shown). This is notable,
because elevated hepatic expression of c-jun accompanies
C/ebpa deletion (Flodby et al., 1996).
We considered four possible mechanisms to account for fatty
liver in TM-challenged Atf6a-null mice: (1) enhanced de novo
synthesis of fatty acids in the liver; (2) increased mobilization and
uptake of fatty acids from adipose tissue to the liver; (3) dimin-
ished fatty acid oxidation by the liver; and (4) decreased lipopro-
tein secretion. Because the genotype-specific changes in gene
expression upon ER stress became evident at later time points
after TM challenge, we used quantitative RT-PCR to probe the
expression of several categories of genes involved in lipid and
carbohydrate homeostasis 48 hr after challenge, when wild-
type animals have largely recovered. The transcriptional regula-
torsC/ebpa (gluconeogenesis and lipogenesis), Ppara (fatty acid
oxidation and gluconeogenesis), Pgc1a (fatty acid oxidation and
gluconeogenesis), Srebp1 (lipogenesis), and ChREBP (a core-
gulator of lipogenesis with SREBP1) all remained significantly
downregulated by persistent ER stress in Atf6a-null livers (Fig-
ure 2F). In contrast, other regulators including other C/ebp family
members, Pparg, Creb, and Lxra, were not significantly affected
by ER stress in these animals. Consistent with these results, we
sampled the expression of key targets of these transcriptional
regulators, finding that genes involved in fatty acid oxidation,
gluconeogenesis, and lipogenesis were all suppressed inAtf6a-null animals (Figure 2G). In addition, genes involved in
lipoprotein synthesis and transport were similarly suppressed,
suggestive of a defect in activity of the transcription factor
SREBP2. Immunoblot confirmed that both uncleaved and
cleaved forms of SREBP1 and SREBP2 were downregulated
in Atf6a-null animals, suggesting that the primary regulation of
their activity after TM injection is transcriptional (data not
shown). Since key proteins involved in lipogenesis (stearoyl-
CoA desaturase-1, FASN, diacylglycerol acyltransferase-2) are
downregulated in Atf6a-null animals, and a key protein that reg-
ulates the formation of new lipid droplets (FIT2 [Kadereit et al.,
2008]) is not affected, de novo lipogenesis in the liver is an un-
likely source of cytosolic lipid droplet formation. Likewise,
Fabp1 suppression implies limited mobilization of fatty acids
from adipose tissue. Taken together, these data suggest that
lipid accumulates in the livers of Atf6a-null animals because of
a defect in fatty acid oxidation, possibly augmented by impaired
lipoprotein secretion. In support of this idea, microvesicular
steatosis can accompany genetic defects in both fatty acid ox-
idation (Rao and Reddy, 2001) and lipoprotein secretion (Raabe
et al., 1999).
ER Stress Sensing Pathways Cooperate to Maintain
Homeostasis and Restore Metabolic Gene Expression
We next turned our attention to the mechanism by which ER
stress leads to the suppression of these transcription factors.
The rapid downregulation of genes encoding metabolic tran-
scription factors by ER stress independent of genotype does
not support the idea that ATF6a directly regulates these genes.
Rather, there more likely exists a difference between wild-type
andAtf6a-null mice that is exacerbated as the latter fail to recover
from TM challenge, which is regulated indirectly by ATF6a. One
noticeable difference between the responses of wild-type and
Atf6a-null livers to TM is thatXbp1mRNA splicing and production
of XBP1 protein from the spliced product persisted in the latter
(Figure 1E and Figure S2). Thus, we considered the possibility
that suppression of metabolic gene expression might depend
upon signaling through the IRE1/XBP1 axis. Ire1a- and Xbp1-
null animals die during embryogenesis because of liver defects
(Reimold et al., 2000; Zhang et al., 2005). To circumvent this prob-
lem, we created animals with a floxed Ire1aallele and mated them
with mice expressing the CRE recombinase under the control of
the albumin promoter, thus generating a liver-specific deletion of
Ire1a. Confirming efficient Ire1a deletion, these animals showed
very little splicing of Xbp1 mRNA in the liver in response to TM
injection (Figure S7).
Rather than being dependent upon IRE1a, the suppression of
metabolic gene expression was exacerbated in liver-specific
Ire1a-null animals in a manner very similar to Atf6a-null animals.
Both forms of C/EBPa protein were downregulated in Ire1a-null
livers 30 hr after TM injection to a much greater extent than in
wild-type animals, while expression of C-JUN was upregulated
(Figure 3A). Liver-specific Ire1a-null animals developed fatty liver(E) Protein lysates from livers of wild-type or Atf6a/ mice injected with vehicle or TM (1 mg/kg) were probed by immunoblot for either C/EBPa (which exists in
a 42 kDa long form and 30 kDa short form) or C-JUN.
(F and G) The expression of metabolic genes subdivided into various categories was determined 48 hr after TM injection by real-time RT-PCR. Red lettering
indicates genes significantly (p < 0.05) different in expression comparing TM-challenged Atf6a-null animals to unchallenged animals.
Data represent means ± SD.
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Adrp along with suppression of transcription factors involved
in lipid metabolism (Figure 3B). As with Atf6a-null animals,
Ire1a-deleted livers showed persistent upregulation of the proa-
poptotic CHOP protein after CHOP upregulation had been
largely attenuated in wild-type animals (Figures 3A and 3B).
Thus, Atf6a-null and Ire1a-null livers display similar sensitivity to
TM and perturbation of metabolic gene expression. While XBP1
has been proposed to regulate basal expression of lipogeneic
genes (Lee et al., 2008), TM-induced steatosis occurs in the
presence of either spliced or unspliced XBP1 (Figures 1E and
3A; Figures S2 and S7B), suggesting that XBP1 does not directly
regulate ER stress-induced microvesicular steatosis.
The similar phenotypes in these two genetic models led us to
ask whether ablating the third, PERK/eIF2a-dependent arm of
the UPR would produce a similar outcome. To test this hypothe-
sis, a constitutively expressed eIF2a transgene flanked by LoxP
sites was introduced into mice harboring the nonphosphorylat-
able S51A mutation in genomic eIF2a. This transgene rescued
the otherwise neonatal lethal eIF2a S51A homozygous mutant,
and either these homozygous (AA) or heterozygous (SA) animals
carrying the transgene were bred to mice expressing CRE under
control of the albumin promoter (see Supplemental Experimental
Procedures and Figure S8). No phosphorylation of eIF2a was
observed in homozygous S51A animals with a deleted transgene
upon TM injection (Figure 3C, lanes 13–16), confirming efficient
eIF2a transgene deletion. As with ATF6a or IRE1a deletion, we
also observed suppression of C/EBPa protein expression, upre-
gulation of C-JUN and ADRP protein, and fatty liver in these ani-
mals, but to a lesser extent in mice heterozygous for the genomic
S51A locus (Figures 3C, compare lanes 10–12 with lanes 13–16;
also, data not shown) Similar results were obtained at the mRNA
level (Figure 3D). Thus, while increased eIF2a dephosphorylation
protects against steatosis induced by severe dietary stress (Oya-
domari et al., 2008), eIF2aphosphorylation is clearly necessary to
prevent fat accumulation in response to a direct challenge of ER
stress.
Our data demonstrate that ongoing ER stress, irrespective of
the UPR pathway ablated, perpetuates suppression of metabolic
gene expression. These results suggest that the UPR protects
lipid homeostasis, not by selective regulation of gene expression
mediated by the ATF6a, IRE1a, or PERK pathways, but instead
by the three pathways of the UPR contributing to overall mainte-
nance of ER function. In this view, the suppression of metabolic
gene expression should be directly responsive to the ER stress
burden in real time, and should correlate with molecular markers
of ER dysfunction. This hypothesis is supported by the following
observations. First, the suppression of C/EBPa expression and
upregulation of C-JUN can be recapitulated in cultured FaO rat
hepatoma cells in response to either TM treatment or induction
of ER stress by the ER calcium-depleting agent thapsigargin
(TG) (Figure 4A). This observation confirms that the effect is not
TM specific, but is likely to be a general consequence of ER
stress. Second, at least one secretory protein was retained intra-
cellularly in Atf6a-null TM-challenged mice. While the gene
encoding serum amyloid protein (SAP) was transcriptionally
Figure 3. Each Arm of the Canonical UPR
Contributes to Protection from Metabolic
Dysregulation
(A) Wild-type mice and mice with a hepatocyte-
specific deletion of Ire1a were injected with
vehicle or TM (2 mg/kg). Protein lysates from liver
isolated 30 hr postinjection were probed by immu-
noblot as indicated. The long (open arrowhead)
and short (closed arrowhead) forms of C/EBPa
are indicated. Note that the apparent difference
in inhibition of TRAPa glycosylation is likely a con-
sequence of this protein itself being a UPR target
at least partially regulated by IRE1a (Nagasawa
et al., 2007), rather than any difference in the phar-
macological efficacy of TM between genotypes.
(B) RNA was prepared from wild-type and Ire1a/
liver tissue samples from (A) and analyzed by
real-time RT-PCR; n = 3 animals per group. Data
represent means ± SD.
(C) eIF2a S51A heterozygous or homozygous
knockin mutant mice, rescued by a constitutively
expressed wild-type eIF2a floxed transgene,
were mated with mice expressing CRE recombi-
nase under control of the albumin promoter to
delete the transgene in hepatocytes. ‘‘eIF2a
genomic’’ denotes whether the mice were hetero-
zygous or homozygous for the S51A genomic
allele, and ‘‘D tg’’ indicates whether or not the transgene was deleted by CRE expression. Protein lysates from liver isolated 30 hr postinjection (2 mg/kg)
were probed by immunoblot as labeled. Here, inhibition of glycosylation was followed using the transferrin receptor (TfR) protein. Asterisk indicates nonspecific
background bands.
(D) Expression of metabolic mRNAs from the animals shown in (C) was quantitated by real-time RT-PCR as in (B); n = 2–4 animals per group. While the difference
in upregulation of Adrp mRNA was not statistically significant comparing SA and AA mice after TM challenge, more robust upregulation of ADRP protein was
evident (data not shown). Red lettering indicates different expression levels comparing Ire1a/ or AA TM-challenged animals to unchallenged, p < 0.1. Data
represent means ± SD.
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type and Atf6a-null animals (Figure S9), its secretion was essen-
tially blocked in the latter, and it was instead detected readily
in the cellular homogenate (Figures 4B and 4C). In addition,
the concentration of plasma cholesterol in the form of ApoB-
containing lipoproteins (VLDL and LDL), was diminished by TM
in both genotypes 24 hr after challenge, but to a greater extent
inAtf6a-null than wild-type animals 48 hr after challenge (Figures
4D and 4E). Together, these data point to suboptimal function
of the secretory pathway during challenge in the livers of
TM-treated UPR-compromised animals.
If the suppression of metabolic gene expression exacerbated
by genetic deficiency of UPR components is in fact causedby dis-
ruption of protein folding and processing in the ER rather than loss
of specific UPR-mediated signaling cascades, then direct pertur-
bation of ER protein folding independent of the UPR should
produce a similar phenotype. To test this prediction, we used
TM to challenge animals nullizygous for the ER-resident DnaJ
protein and binding protein (BiP) cochaperone p58IPK (Ladiges
et al., 2005). p58-null cells and animals are more sensitive to ER
stress than wild-type counterparts, most likely due to the role
for p58IPK in enhancing BiP-dependent protein folding (Rutkowski
et al., 2007). Strikingly,p58-null animals developed fatty liver after
TM injection (Figure 5A) and suppressed expression of C/ebpa
(Figures 5B and 5C). As with Atf6a-null and Ire1a-null animals,
p58-null animals also showed persistent CHOP upregulation
after challenge (Figures 5B and 5C). Thus, the suppression of
metabolic genes, such as C/ebpa, is a direct consequence of
ER stress and not dependent upon any single pathway of UPR
signaling.
Compromised ER Protein Folding SuppressesMetabolic
Gene Expression Partially through CHOP
The rapid downregulation ofC/ebpamRNA and others during ER
stress could be explained by either induced degradation of these
mRNAs, or by inhibition of new synthesis. To discriminate be-
tween these possibilities, we treated FaO hepatoma cells with
TM or TG in the presence or absence of the transcription inhibitor
actinomycin D (ActD). In the absence of stress, ActD alone dra-
matically reduced C/EBPa expression, and it essentially nullified
the effect of TM or TG on C/EBPa (Figure 6A). Therefore, C/ebpa
mRNA is basally degraded very rapidly in hepatocytes, and its
stress-mediated downregulation is most likely due to inhibition
of its transcription.
One commonality among the Atf6a, Ire1a, and p58 genetic
models presented here is persistent upregulation and nuclear
localization of CHOP as a consequence of ongoing stress, while
CHOP is rapidly, but only transiently, upregulated in response to
TM challenge in wild-type mice (Figures 1A; Figures S10 and
S11). CHOP is a member of the C/EBP family of transcription
factors, and has been proposed to be a dominant-negative reg-
ulator of their function (Ron and Habener, 1992). We considered
the possibility that CHOP upregulation during stress is at least
partially responsible for the suppression of metabolic gene ex-
pression. Upon challenge of Chop-null animals with TM, expres-
sion of the transcriptional regulators C/ebpa, Ppara, Pgc1a, and
Srebp1 was less suppressed than in wild-type animals (Fig-
ure 6B). This was also observed upon analysis of C/EBPa protein
(Figure 6C). Chop deletion also partially protected against lipid
accumulation, seen in reduced upregulation of ADRP (Figure 6C).
Thus, CHOP forms at least a component of the mechanistic
Figure 4. Disruption of ER Protein Process-
ing Suppresses Metabolic Gene Expression
(A) FaO rat hepatoma cells were treated in dupli-
cate with 500 nM TG or 5 mg/ml TM for 8 or
24 hr, followed by cell lysis and immunoblot for
GRP94, BiP, C/EBPa, and C-JUN. In hepatocytes,
slower-migrating phospho-C-JUN, induced by ER
stress, is also observed.
(B and C) Wild-type and Atf6a/ mice were
injected with vehicle or TM (1 mg/kg bodyweight).
Protein lysates from liver isolated at the indicated
time points after injection were probed by immu-
noblot for intracellular serum amyloid protein
(SAP) (B); Plasma level of SAP was assayed by
ELISA (C).
(D) Total cholesterol and triglyceride levels were
measured by enzymatic assay from plasma sam-
ples of mice injected with vehicle or TM for 24 hr,
with a 6 hr fast preceding death. Data represent
means ± SD.
(E) Cholesterol and triglyceride represented either
as total content, or in the form of LDL and VLDL
particles purified by differential precipitation, was
measured as in (D). In this case samples were col-
lected 48 hr after TM injection rather than 24 hr.
Note that the absolute values are somewhat differ-
ent comparing (D) and (E), likely due to experimen-
tal variation. However, in (D) there is no significant
difference in either cholesterol or triglyceride
levels between genotypes after TM injection, while cholesterol levels recover to a greater extent in wild-type animals than Atf6a-null animals in (E). The fact
that TM has a much greater effect on cholesterol-rich lipoprotein particles than triglyceride-rich particles suggests that TM inhibits liver lipoprotein production
but not intestinal production. Data represent means ± SD; *p < 0.05.
Developmental Cell 15, 829–840, December 9, 2008 ª2008 Elsevier Inc. 835
Developmental Cell
Unresolved ER Stress Causes Steatosislinkage between persistent ER stress and the suppression of
transcription factors like C/EBPa.
CHOP was persistently upregulated by stress in our genetic
models, from early through late time points, despite lack of an
apparent stimulation of eIF2a phosphorylation, which is presum-
ably a consequence of persistent upregulation of GADD34
downstream of CHOP (Marciniak et al., 2004; Wu et al., 2007)
(Figure 1A). Conversely, in wild-type animals, CHOP upregula-
tion is rapidly attenuated despite persistent stimulation of
eIF2a phosphorylation. Surprisingly, we found that ATF4 was
also upregulated by ER stress in Atf6a/ animals at both early
and late time points (Figure 6D and data not shown). These
data suggest that the upregulation of CHOP, which then influ-
ences lipid metabolism, occurs through a dissociation of ATF4
protein levels from the phosphorylation status of eIF2a by
a mechanism that is the subject of ongoing investigation.
Figure 5. Disrupted ER Protein Folding
Leads to Steatosis Despite an Intact UPR
(A–C) Wild-type and p58IPK/ mice were injected
with vehicle or TM (1 mg/kg) and sacrificed 48 hr
postinjection. (A) Livers from TM-challenged mice
were visualized in situ. (B) Protein lysates from
livers were probed by immunoblot as indicated.
(C) RNA was analyzed by real-time RT-PCR. Red
lettering represents p < 0.05 comparing p58/
treated to untreated. Data represent means ± SD.
Figure 6. CHOP Suppresses Expression of
Metabolic Transcription Factors
(A) FaO rat hepatoma cells were treated in dupli-
cate with 5 mg/ml actinomycin D (ActD) and no
stress, 500 nM TG, or 5 mg/ml TM for 4 hr. Protein
lysates were then harvested and probed by immu-
noblot as indicated. Note that ActD treatment
completely blocks the upregulation of BiP and
CHOP, as expected.
(B and C) Wild-type and Chop/ mice were in-
jected with vehicle or TM (1 mg/kg) and sacrificed
24 hr after injection. (B) RNA was analyzed by
real-time RT-PCR as in Figure 2D; n = 4–10 ani-
mals per group. Red lettering represents p < 0.05
comparing Chop/ treated to wild-type treated.
Data represent means ± SD. (C) Protein lysates
from liver were probed by immunoblot, as indi-
cated.
(D) Nuclear lysates from TM-injected wild-type or
Atf6a-null animals (48 hr) were probed for immu-
noblot, as indicated.
Hepatic Fat Accumulation
Accompanies Diverse ER Stresses
The diversity of physiological causes of
hepatic microvesicular steatosis led us
to ask whether other less severe forms of
ER stress could also lead to fat accumula-
tion and suppression of C/EBPa expres-
sion. Remarkably, the proteasome inhibitor bortezomib, which is
used clinically to treat multiple myeloma, led to lipidaccumulation,
as seen by ADRP upregulation (Figure 7A). Published reports sug-
gest possible hepatoxicity of bortezomib (Hernandez-Espinosa
et al., 2008; Rosinol et al., 2005). In addition, ADRPand C-JUN up-
regulation and suppression of lipogenic genes were also seen as
a consequence of overexpression of the misfolding-prone factor
VIII clotting protein (Figure S12). Thus, lipid accumulation and
suppression of C/EBPa are conserved features of the hepatic
response to ER stress in general.
Conclusions
Our data demonstrate that protection of ER homeostasis by the
combined action of the three UPR pathways maintains meta-
bolic function in part by suppressing CHOP expression and the
attendant downregulation of genes involved in lipid and energy
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hensive genetic approach to understand how the pathways of
the vertebrate UPR contribute to the homeostasis of an organ
in vivo. Our data allow us to propose a model to describe the
proximal events that connect ER stress to lipid homeostasis
(Figure 7B). Exposure to ER stress activates all three ER-resident
sensors, IRE1a, ATF6a, and PERK. Activation of these sensors
induces expression both of genes that facilitate adaptation
and/or recovery, such as ER chaperones, and also of antiadap-
tive genes, including Chop. One of the consequences of Chop
upregulation is suppression of genes involved in lipid homeosta-
sis, likely mediated through dominant-negative inhibition of
C/EBP family members by CHOP.
We conclude that negative regulation ofC/ebpa by CHOP is of
key importance in metabolic dysregulation by ER stress, in part
because the phenotypes that we observe—fatty liver, hypoglyce-
mia, and depletion of hepatic glycogen—are also observed upon
postnatal deletion of C/ebpa, as are many similar changes in
gene expression profiles, including expression of metabolic tran-
scriptional regulators (Yang et al., 2005). Indeed, potential bind-
ing sites for C/ebpa exist in the promoters of Ppara and Srebp1
(Villacorta et al., 2007). It seems most plausible that ER stress
will lead to suppression of C/ebpa, partially through CHOP and
consequent suppression of other master regulators of metabolic
gene expression, such as Srebp1, Ppara, and Pgc1a. Thus, we
speculate that unresolved ER stress recapitulates a knockdown
of C/EBPa. Whether C/EBPa suppression alone is sufficient to
drive these changes, and whether CHOP alone is sufficient to
negatively regulate C/EBPa expression, are the subject of ongo-
ing investigation, and we believe it likely that other as-yet
unknown mechanisms contribute as well. Furthermore, which in-
dividual metabolic transcription factors actually directly control
fatty acid oxidation under these circumstances is not clear. It is
possible that steatosis might be driven entirely by downregula-
tion of PGC1a and/or PPARa, both of which ordinarily control
fatty acid oxidation. Thus, it will be important to elucidate the hi-
erarchy of genetic regulation downstream of CHOP and C/EBPa.
Our results suggest that an initial perturbation—even a tran-
sient one—will initiate changes in gene regulation that impact
lipid metabolism. Assuming that the adaptive response is suffi-
cient to overcome the perturbation, the UPR is then largely deac-
tivated, and production of proteins involved in lipid metabolism is
restored due to rapid degradation of CHOP (Rutkowski et al.,
2006). However, if the stress is too severe (elicited, in this case,
by genetic compromise of either UPR pathways or ER quality
control), then CHOP-directed suppression of gene expression
persists, leading to profound metabolic disruption. Our data
support the idea that each of the UPR pathways contributes to
adaptation and/or recovery, and that the overlap of UPR targets
ensures that the strongest predictor of recovery versus ongoing
stress is the expression of adaptive (e.g., ER chaperones) versus
antiadaptive (e.g., CHOP) downstream gene products (Rutkow-
ski et al., 2006).
An important question for future work is what components of
the ER stress-lipid homeostasis nexus facilitate adaptation, and
are thus likely to be observed in the course of adaptation to
chronic disruptions of liver function, versus those that are purely
consequences of severe stress and represent metabolic dys-
function. Indeed, while steatosis accompanies organismal sus-
ceptibility to ER stress in Atf6a-null models, the cause of death
of these animals is not yet known, and inhibition of fatty acid
oxidation and lipoprotein secretion might even be protective, at
least in certain physiological circumstances. The topic of the
role of components of the UPR in regulating lipid homeostasis
has been the subject of very recent attention. Both XBP1 and
eIF2a have been shown to participate in basal and/or diet-in-
duced regulation of lipid metabolism (Lee et al., 2008; Oyadomari
et al., 2008). We have observed, in a model cultured cell system,
that cells adapted to chronic ER stress paradoxically become
more resistant to further challenge than naı¨ve cells (Rutkowski
et al., 2006). Thus, the extent to which dietary stresses might
allow for gradual adaptation of UPR-deficient cells, while focal
stresses might not, could significantly impact the resultant phe-
notype. Indeed, the observation that C/EBPa expression appar-
ently promotes steatosis in the dietary context (Oyadomari et al.,
2008), while its downregulation promotes steatosis in response
to ER stress (this work), is reminiscent of the observation that
constitutive embryonic deletion of C/EBPa prevents hepatic lipid
Figure 7. Diverse ER Stresses Lead to Lipid Accumulation
(A) Normal mice were injected intravenously with the proteasome inhibitor Velcade (bortezomib) at a dose of 1 mg/kg and sacrificed 8 hr after injection. Lysates
were probed for upregulation of CHOP, ADRP, and C-JUN.
(B) A schematic diagram depicting the joint role of the ATF6, PERK, and IRE1 pathways in maintaining lipid homeostasis. Failure of the UPR to adequately protect
the ER results in ongoing production of CHOP, which suppresses metabolic genes via C/EBPa and ultimately leads to disruption of fatty acid oxidation, lipopro-
tein secretion, gluconeogenesis, and other metabolic processes.
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Unresolved ER Stress Causes Steatosisaccumulation (Flodby et al., 1996; Wang et al., 1995), while
deletion in the adult exacerbates it (Yang et al., 2005). Whether
our study and the recent XBP1 and eIF2a papers together repre-
sent three faces of the same basic signaling pathway or, alterna-
tively, whether they illuminate the mechanisms of different forms
of hepatic dysfunction, remains to be investigated.
Our work demonstrates a direct connection between ER
dysfunction and the regulation of lipid metabolism through the
protective role of the UPR. These findings raise the possibility




Many of the techniques described here, including RNA and protein analysis,
utilized previously published reagents and standard experimental techniques
(Rutkowski et al., 2006; Wu et al., 2007; and references therein).
Animal Experiments
All protocols for animal use were reviewed and approved by the University
Committee on Use and Care of Animals at the University of Michigan. Animals
were fed standard rodent chow and housed in a controlled environment with
12 hr light-dark cycles. Littermate controls were used for all experiments
where possible, and age and gender were matched for each experiment,
though neither of these variables was observed to have any effect on the phe-
notype. Plasma from blood samples was collected by cardiac puncture using
a BD Microtainer with lithium herapin. Plasma levels of SAP were determined
using the murine SAP ELISA kit (Immunology Consultants Laboratory, Inc.). TM
injections were as previously described (Zinszner et al., 1998). Insulin injection
was intraperitoneal with 2 U/kg body weight. Plasma and liver cholesterol and
triglyceride levels were determined as previously described (Iqbal et al., 2008a,
2008b). Velcade (bortezomib, from Millenium) was administered intravenously
at a dose of 1 mg/kg, and mice were sacrificed 8 hr after treatment.
Array Analysis
Mice were injected intraperitoneally with 2 mg/kg body weight of TM, or vehi-
cle, and livers were isolated 8 hr after injection. Total RNA was isolated using
RNeasy (QIAGEN) and analyzed by the University of Michigan Comprehensive
Cancer Center Affymetrix and cDNA Microarray Core Facility (Ann Arbor,
Michigan), exactly as described previously (Wu et al., 2007).
Protein and RNA Analysis
Briefly, tissue was homogenized using an electronic homogenizer in RIPA
buffer containing protease inhibitors or in Trizol RNA reagent (Invitrogen),
and centrifuged at 15,000 rpm for 10 min in a microfuge at 4C. RNA was
isolated using TRIzol RNA reagent or RNeasy (QIAGEN), according to the man-
ufacturers’ protocols. Additional real-time primer sequences are described in
the Supplemental Data (Table S2).
Histological Analysis of Tissues
Livers were prepared for electron microscopy by fixing liver tissue using 2.5%
glutaraldehyde in 0.1 M phosphate salt buffer (pH 7.4). Samples were pro-
cessed and imaged as previously described (Rutkowski et al., 2006). For
H&E staining, liver tissues were frozen in OCT in liquid nitrogen-cooled 2-meth-
ylbutane. The sections were cut to 6 mm. Livers were visualized in situ using
a Leica MZ16FA stereomicroscope.
Cell Culture and Analysis
FaO rat hepatoma cells were from ATCC and cultured in DMEM medium with
10% fetal bovine serum. Treatment of cells with TM or TG was as previously
described (Rutkowski et al., 2006).
Generation of Mouse Models
Creation of Atf6a-null, p58IPK-null, and Chop-null mice has been described
elsewhere (Ladiges et al., 2005; Wu et al., 2007; Zinszner et al., 1998).838 Developmental Cell 15, 829–840, December 9, 2008 ª2008 ElseeIF2aAA:tg/+:Alb-cremice were created by introduction of a transgene encod-
ing constitutively expressed wild-type eIF2a flanked by LoxP sites into the
eIF2a S51A knockin background (S.H.B. and R.J.K., unpublished data). These
mice were then bred to mice expressing CRE recombinase under control of the
albumin promoter for liver-specific transgene deletion. Similarly, liver-specific
Ire1a knockout mice were created by embryonic stem-targeted homologous
recombination of exons 16 and 17 flanked by LoxP sites. Mating to albumin-
CRE-expressing mice allowed for liver-specific deletion of these exons,
resulting in loss of the IRE1a kinase domain. Additional information for
eIF2aAA:tg/+:Alb-cremice can also be found in the Supplemental Experimental
Procedures. Ire1a deletion is described in the supplemental materials section
of (Sakaki et al., 2008).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, twelve
figures, and three tables and can be found with this article online at http://
www.cell.com/developmentalcell/supplemental/S1534-5807(08)00475-9/.
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